Col. Suthee Panichkul
Quick facts
Marketed products
- Ivabradine and Metoprolol · Cardiovascular
This combination reduces heart rate through dual action: ivabradine selectively inhibits the If channel in the sinoatrial node, while metoprolol blocks beta-1 adrenergic receptors.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: